[The effect of cephalexin on thrombocyte function in diabetics and normal persons].
Studies on the Effect of Cephalexin on Platelet Functions in Diabetics and Healthy Volunteers. The effect of cephalexin (Ceporexin) on platelet functions of diabetics with proliferative retinopathy and of healthy volunteers was studied. Cephalexin, 3 X 1 g for 7 days, reduced epinephrine- and collagen-induced platelet aggregation of the diabetics in a significant, but clinically not relevant manner. Platelet factor-3 availability and retraction remained unaffected by treatment with cephalexin. Cephalexin in vitro in a concentration of 500 mg/l reduced the rate and peak amplitude of platelet aggregation in diabetics and healthy volunteers to the same extent. The in vitro inhibition of epinephrine- and collagen-induced platelet aggregation was lacking clinical relevance. Platelet factor-3 availability was not changed by addition of cephalexin in vitro; the retraction was significantly increased, however, without clinical relevance.
Peters
K M
KM
Chirurgischen Universitätsklinik, Köln.
Reuter
H D
HD
D000328:Adult; D000368:Aged; D001792:Blood Platelets / Q000187:drug effects*; D002506:Cephalexin / Q000494:pharmacology*; D003920:Diabetes Mellitus / Q000097:blood*; D003930:Diabetic Retinopathy / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D010977:Platelet Factor 3 / Q000378:metabolism
D010977:Platelet Factor 3; D002506:Cephalexin
Untersuchungen zum Einfluss von Cephalexin auf die Thrombozytenfunktionen von Diabetikern und Normalpersonen.